Pharma Journalist 8887 posts 0 comments

Regeneron Pharmaceuticals said the European Medicines Agency (EMA) has accepted for review under its Accelerated Assessment pathway the Marketing Authorization Application (MAA) for…
Read More...

Concept Life Sciences has entered a strategic partnership with OpenBench to accelerate early-stage drug discovery for biotechnology companies through a success-based artificial…
Read More...

Bristol Myers Squibb and Anthropic have entered a strategic agreement to deploy Anthropic’s Claude artificial intelligence platform across Bristol Myers Squibb’s global operations,…
Read More...

FUJIFILM Cellular Dynamics has inaugurated a new headquarters and induced pluripotent stem cell (iPSC) development and manufacturing facility in Madison, Wisconsin, significantly…
Read More...

Eli Lilly and Company reported positive topline results from its Phase 3 TRIUMPH-1 clinical trial, showing that investigational obesity treatment retatrutide delivered substantial and…
Read More...

Gilead Sciences has completed its previously announced acquisition of Germany-based biotechnology company Tubulis GmbH, strengthening its oncology pipeline with next-generation…
Read More...

Gilead Sciences has renewed its collaboration with the World Health Organization (WHO) for another five years, strengthening efforts to eliminate visceral leishmaniasis (VL), commonly…
Read More...

Johnson & Johnson has partnered with the Department of Health – Abu Dhabi to launch a global initiative aimed at building an open surgical intelligence network, positioning Abu…
Read More...

Regeneron Pharmaceuticals reported encouraging early-stage results from a Phase 1/2 clinical trial evaluating Lynozyfic (linvoseltamab) in patients with relapsed or treatment-resistant…
Read More...

Eli Lilly and Company has acquired preclinical biotechnology company Engage Biologics Inc. in a deal worth up to $202 million, strengthening the drugmaker’s ambitions in next-generation…
Read More...